Manufacturer
Brand Dragon Pharma
Last Lab Tested None
Core Information
Substance AOD-9604 (HGH Fragment 176–191)
Classification Lipolytic peptide
Active Half-Life 2–4 hours
Typical Dosage (Men) 250–500 mcg/day
Effects & Properties
Water Retention No
Aromatization No
Hepatotoxicity No
Hair Loss Risk (HBR) No
Acne No
Dragon Pharma AOD 9604 | Fat Loss & Body Recomposition Peptide
Dragon Pharma AOD 9604 is a specialized fat-loss peptide designed to support lipolysis, metabolic activity, and body recomposition without the broader anabolic effects commonly associated with full human growth hormone therapy.
Derived from the HGH Fragment 176-191 sequence, AOD 9604 was developed to target fat metabolism while minimizing unwanted hormonal stimulation linked to traditional HGH compounds.
Unlike standard HGH or somatropin therapy, Dragon Pharma AOD 9604 primarily focuses on fat oxidation and adipose tissue metabolism rather than major IGF-1 elevation or muscle hypertrophy.
What Is AOD 9604?
AOD 9604 is a modified fragment of human growth hormone consisting of amino acids 176-191. It was developed to isolate the fat-metabolizing effects of HGH while reducing broader endocrine activity.
Common goals associated with AOD 9604 include:
- Supporting lipolysis and fat mobilization
- Reducing lipogenesis (fat storage)
- Enhancing metabolic efficiency
- Supporting gradual body fat reduction
- Preserving lean body composition during cutting phases
How Dragon Pharma AOD 9604 Works
Dragon Pharma AOD 9604 works by influencing pathways involved in fat metabolism and energy utilization. The peptide may help stimulate the breakdown of stored fatty acids while reducing new fat accumulation.
Mechanisms Associated with AOD 9604
- Increased lipolysis activity
- Enhanced fatty acid mobilization
- Support for metabolic flexibility
- Reduced fat accumulation potential
- Improved calorie utilization during dieting phases
Unlike stimulant-based fat burners, AOD 9604 is not designed to artificially increase CNS activity. Instead, it targets metabolic signaling pathways related to growth hormone fat regulation.
Performance & Body Recomposition Benefits
- ✔ Gradual body fat reduction support
- ✔ Improved physique definition
- ✔ Better recomposition outcomes
- ✔ Lean tissue preservation during cutting
- ✔ Enhanced recovery while dieting
- ✔ Improved metabolic efficiency
- ✔ Compatible with cutting and peptide stacks
AOD 9604 Dosage & Cycle Structure
Experience Level Typical Dosage: 250 mcg daily
Intermediate: 300 - 500 mcg daily
Advanced: Up to 500 mcg daily
Typical Cycle Structure
- Cycle duration: 4 - 12 weeks
- Administration: Subcutaneous injection
- Timing: Morning or fasted administration
Consistency is generally considered more important than aggressive dosing protocols.
Popular Stacking Applications
Dragon Pharma AOD 9604 is commonly combined with other peptides and recovery compounds during cutting and recomposition phases.
Common Stack Combinations
Potential goals of these combinations include:
- Better recovery
- Improved sleep quality
- Enhanced fat metabolism
- Joint and tissue support
- Lean tissue preservation
Side Effects & Safety Profile
Compared to full HGH therapy, AOD 9604 side effects are generally considered milder due to its limited systemic hormonal activity.
Potential Side Effects
- Mild injection site irritation
- Temporary headaches
- Mild fatigue
- Water retention in sensitive individuals
- Nausea or digestive discomfort
Unlike traditional HGH therapy, AOD 9604 is not strongly associated with major IGF-1 elevation or severe insulin resistance under standard protocols.
AOD 9604 vs HGH & Secretagogues
| AOD 9604 |
Traditional HGH |
| Primarily targets fat metabolism |
Broader anabolic effects |
| Minimal IGF-1 stimulation |
Significant IGF-1 elevation |
| Commonly used for cutting |
Used for growth and recovery |
AOD 9604 vs GH Secretagogues
- CJC-1295: Stimulates endogenous GH release
- Ipamorelin: Amplifies GH pulse secretion
- AOD 9604: Acts more directly on fat metabolism pathways
Quality & Product Assurance
- ✔ Verified peptide formulation
- ✔ Pharmaceutical-grade manufacturing standards
- ✔ Secure packaging & discreet shipping
- ✔ Batch consistency verification
- ✔ International availability
Conclusion
Dragon Pharma AOD 9604 is a targeted AOD 9604 peptide designed to support fat metabolism, lipolysis, and body recomposition without the stronger systemic hormonal effects commonly associated with traditional HGH therapy.
Standard AOD 9604 dosage protocols typically range between 200–500 mcg daily, helping support fat oxidation and metabolic activity while maintaining minimal impact on IGF-1 levels and glucose regulation.
Most users run AOD 9604 peptide cycles for 4–12 weeks depending on physique and recovery goals:
4 - 8 weeks for cutting and recomposition phase;
8 - 12 weeks for long-term metabolic support;
4 - 6 weeks for recovery-focused protocols.
For best results, Dragon Pharma AOD 9604 is commonly combined with structured nutrition, cardio, resistance training, and peptide stacks such as CJC-1295, Ipamorelin, or recovery compounds like BPC-157. Reported AOD 9604 side effects are generally mild and may include temporary injection-site irritation, fatigue, or mild bloating depending on dosage and individual response.
Overall, Dragon Pharma AOD 9604 offers a non-stimulant approach to supporting fat loss and metabolic efficiency, making it a useful addition to a structured cutting or body recomposition protocol rather than a standalone solution.